Regulation of tumour necrosis factor signalling: live or let die
Open accessAbstract
Tumour necrosis factor (TNF) is a pro-inflammatory cytokine that has important roles in mammalian immunity and cellular homeostasis. Deregulation of TNF receptor (TNFR) signalling is associated with many inflammatory disorders, including various types of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases. This Review focuses on the recent advances that have been made in understanding TNFR signalling and the consequences of its deregulation for cellular survival, apoptosis and regulated necrosis. We discuss how TNF-induced survival signals are distinguished from those that lead to cell death. Finally, we provide a brief overview of the role of TNF in inflammatory and autoimmune diseases, and we discuss up-to-date and future treatment strategies for these disorders.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Biological outcome of TNFR1 signaling spans from cell survival and activation to multiple subroutines of RCD, depending on cell-intrinsic and cell-extrinsic factors.
“As mentioned above, the biological outcome of TNFR1 signaling spans from cell survival and activation (i.e., cytokine secretion) to multiple subroutines of RCD, depending on a variety of cell-intrinsic (e.g., expression levels of the proteins involved in the process) and cell-extrinsic (e.g., intensity and duration of TNF stimulation) factors [283].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [283]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Part of this paper’s reference list could not be split into single entries.
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840 · see citing works
Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679 · see citing works
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513 · see citing works
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399 · see citing works
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149 · see citing works
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · see citing works
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046 · see citing works
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · see citing works
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738 · see citing works
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709 · see citing works
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698 · see citing works
Suppression of TNF-α-Induced Apoptosis by NF-κB
Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581 · see citing works
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,548 · see citing works
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I. E., Matteson, E. L., & Montori, V. M. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,470 · see citing works
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435 · see citing works
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421 · see citing works
Molecular mechanisms of necroptosis: an ordered cellular explosion
Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., & Kroemer, G. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2970 · Cited by 2,382 · see citing works
Beutler, B., Milsark, I. W., & Cerami, A. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,369 · see citing works
Purification and Characterization
Tsai, C. S. (2006) · Biomacromolecules · doi:10.1002/0470080124.ch3 · Cited by 2,368 · see citing works
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214 · see citing works
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125 · see citing works
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · see citing works
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,024 · see citing works
Hsu, H., Shu, H., Pan, M., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998 · see citing works
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,932 · see citing works
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931 · see citing works
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O’Rourke, K. M., Zhou, H., Eby, M. T., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R. T., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,852 · see citing works
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,675 · see citing works
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R., Weaver, A. L., Ettlinger, R. E., Cohen, S. B., Koopman, W. J., Mohler, K. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,620 · see citing works
Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L., Wang, F., & Wang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.003 · Cited by 1,564 · see citing works
TNF-α Induces Two Distinct Caspase-8 Activation Pathways
Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,352 · see citing works
Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322 · see citing works
A novel domain within the 55 kd TNF receptor signals cell death
Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290 · see citing works
Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011) · Nature · doi:10.1038/nature09852 · Cited by 1,278 · cited 3× · see citing works
“This crucial interplay between the inhibition of caspase activity and RIPK1-and RIPK3-mediated necrotic cell death has been clearly demonstrated by the finding that genetic deletion of RIPK1 and/or RIPK3 rescues the lethality observed in caspase 8-deficient or FADD-deficient mice 86,87,106–108 .”
BackgroundLi, J., McQuade, T., Siemer, A. B., Napetschnig, J., Moriwaki, K., Hsiao, Y.-S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.019 · Cited by 1,222 · see citing works
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220 · see citing works
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218 · see citing works
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190 · see citing works
TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling Complex
Hsu, H., Huang, J., Shu, H.-B., Baichwal, V., & Goeddel, D. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80252-6 · Cited by 1,182 · see citing works
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,151 · see citing works
Brennan, F. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,133 · see citing works
Bertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J. P., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,102 · see citing works
Kriegler, M., Perez, C. F., DeFay, K., Albert, I., & Lu, S.-D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,090 · see citing works
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
Vince, J. E., Wong, W. W.-L., Khan, N. R., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,061 · see citing works
RIP3 mediates the embryonic lethality of caspase-8-deficient mice
Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., Caspary, T., & Mocarski, E. S. (2011) · Nature · doi:10.1038/nature09857 · Cited by 1,057 · see citing works
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V. J., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,050 · see citing works
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022 · see citing works
lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis
Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,021 · see citing works
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,018 · see citing works
Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 998 · see citing works
Hitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989 · see citing works
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1821 · Cited by 943 · see citing works
Linear ubiquitination prevents inflammation and regulates immune signalling
Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940 · see citing works
Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Loo, G., Declercq, W., Grooten, J., Fiers, W., & Vandenabeele, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1477 · Cited by 925 · see citing works
Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 917 · see citing works
Circuitry of nuclear factor κB signaling
Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907 · see citing works
Zhao, J., Jitkaew, S., Cai, Z., Choksi, S., Li, Q., Luo, J., & Liu, Z.-G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200012109 · Cited by 901 · see citing works
TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains
Kanayama, A., Seth, R. B., Sun, L., Ea, C.-K., Hong, M., Shaito, A. A., Chiu, Y., Deng, L., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.008 · Cited by 890 · see citing works
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877 · see citing works
Structural basis of IAP recognition by Smac/DIABLO
Wu, G., Chai, J., Suber, T. L., Wu, J., Du, C., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35050012 · Cited by 863 · see citing works
Feoktistova, M., Geserick, P., Kellert, B., Panayotova‐Dimitrova, D., Langlais, C., Hupe, M., Cain, K., MacFarlane, M., Häcker, G. A., & Leverkus, M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.011 · Cited by 855 · see citing works
The IKK Complex, a Central Regulator of NF- B ActivationPreprint
Israël, A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000158 · Cited by 853 · see citing works
Tenev, T., Bianchi, K., Darding, M., Broemer, M., Langlais, C., Wållberg, F., Zachariou, A., Lopez, J. S., MacFarlane, M., Cain, K., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.006 · Cited by 818 · see citing works
NF-κB Signals Induce the Expression of c-FLIP
Micheau, O., Lens, S. M. A., Gaide, O., Alevizopoulos, K., & Tschopp, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5299-5305.2001 · Cited by 809 · see citing works
Tumor necrosis factor identified in multiple sclerosis brain.
Hofman, F. M., Hinton, D. R., Johnson, K. P., & Merrill, J. E. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.2.607 · Cited by 801 · see citing works
Yeh, W., Shahinian, A., Speiser, D. E., Kraunus, J., Billia, F., Wakeham, A. C., de la Pompa, J. L., Ferrick, D. A., Hum, B., Iscove, N. N., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80391-x · Cited by 798 · see citing works
Self-citationAdvances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J. H., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 789 · see citing works
Origin and function of ubiquitin-like proteins
Hochstrasser, M. (2009) · Nature · doi:10.1038/nature07958 · Cited by 784 · see citing works
Chen, X., Li, W., Ren, J., Huang, D., He, W., Song, Y., Yang, C., Li, W., Zheng, X., Chen, P., et al. (2013) · Cell Research · doi:10.1038/cr.2013.171 · Cited by 778 · see citing works
A ubiquitin ligase complex assembles linear polyubiquitin chains
Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., Sano, S., Tokunaga, F., Tanaka, K., & Iwaï, K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601360 · Cited by 772 · see citing works
Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J. E., Warnken, U. H., Wenger, T., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.013 · Cited by 768 · see citing works
Tang, W., Lu, Y., Tian, Q.-Y., Zhang, Y., Guo, F.-J., Liu, G.-Y., Syed, N. M., Lai, Y., Lin, E. A., Kong, L., et al. (2011) · Science · doi:10.1126/science.1199214 · Cited by 761 · see citing works
SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis
Ikeda, F., Deribe, Y. L., Skånland, S. S., Stieglitz, B., Grabbe, C., Franz-Wachtel, M., van Wijk, S. J. L., Goswami, P., Nagy, V., Terzic, J., et al. (2011) · Nature · doi:10.1038/nature09814 · Cited by 745 · see citing works
Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation
Rahighi, S., Ikeda, F., Kawasaki, M., Akutsu, M., Suzuki, N., Kato, R., Kensche, T., Uejima, T., Bloor, S., Komander, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.007 · Cited by 745 · see citing works
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoPreprint
Shim, J., Xiao, C., Paschal, A. E., Bailey, S. T., Rao, P., Hayden, M. S., Lee, K., Bussey, C., Steckel, M., Tanaka, N., et al. (2005) · Genes & Development · doi:10.1101/gad.1360605 · Cited by 735 · see citing works
Autoimmune Diseases Induced by TNF-Targeted Therapies
Ramos‐Casals, M., Brito‐Zerón, P., Muñoz, S., Soria, N., Galiana, D., Bertolaccini, M. L., Cuadrado, M. J., & Khamashta, M. A. (2007) · Medicine · doi:10.1097/md.0b013e3181441a68 · Cited by 731 · see citing works
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706 · see citing works
Small-Molecule Inhibition of TNF-α
He, M. M., Stroustrup, A., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 626 · see citing works
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex
Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S.-I., Tanaka, K., Nakano, H., & Iwai, K. (2011) · Nature · doi:10.1038/nature09815 · Cited by 609 · see citing works
Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T. L., Yang, X., Yeh, W., Mak, T. W., et al. (2008) · Nature Immunology · doi:10.1038/ni.1676 · Cited by 607 · see citing works
Self-citationSensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation
Wu, C.-J., Conze, D. B., Li, T., Srinivasula, S. M., & Ashwell, J. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1384 · Cited by 607 · see citing works
The Structure of Tumor Necrosis Factor-α at 2.6 Å Resolution
Eck, M. J., & Sprang, S. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71533-0 · Cited by 585 · see citing works
Anti-TNF-α therapies: the next generation
Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 579 · see citing works
Molecular discrimination of structurally equivalent Lys 63‐linked and linear polyubiquitin chains
Komander, D., Reyes‐Turcu, F. E., Licchesi, J. D. F., Odenwälder, P., Wilkinson, K. D., & Barford, D. (2009) · EMBO Reports · doi:10.1038/embor.2009.55 · Cited by 575 · see citing works
Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis
Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J. D., Harran, P. G., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 572 · see citing works
Ting, A. T., Pimentel‐Muiños, F. X., & Seed, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01007.x · Cited by 550 · see citing works
Newton, K., Sun, X., & Dixit, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1464-1469.2004 · Cited by 544 · see citing works
Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation
Mahoney, D. J., Cheung, H. H., Mrad, R. L., Plenchette, S., Simard, C., Enwere, E., Arora, V., Mak, T. W., Lacasse, E. C., Waring, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711122105 · Cited by 540 · see citing works
Self-citationThe structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.
Eck, M. J., & Sprang, S. R. (1989) · PubMed · doi:10.2210/pdb1tnf/pdb · Cited by 507 · see citing works
Structure of tumour necrosis factor
Jones, E. Y., Stuart, D. I., & Walker, N. P. C. (1989) · Nature · doi:10.1038/338225a0 · Cited by 503 · see citing works
Lavrik, I. N., Golks, A., & Krammer, P. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.01610 · Cited by 494 · see citing works
Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation
Legler, D. F., Micheau, O., Doucey, M., Tschopp, J., & Bron, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00092-x · Cited by 464 · see citing works
Clinical targeting of the TNF and TNFR superfamilies
Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 457 · see citing works
Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
Wu, J., Huang, Z., Ren, J., Zhang, Z., He, P., Li, Y., Ma, J., Chen, W., Zhang, Y., Zhou, X., et al. (2013) · Cell Research · doi:10.1038/cr.2013.91 · Cited by 452 · see citing works
TNF receptor 2 pathway: drug target for autoimmune diseases
Faustman, D., & Davis, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3030 · Cited by 446 · see citing works
Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain
Feng, S., Yang, Y., Mei, Y., Ma, L., Zhu, D.-E., Höti, N., Castanares, M. A., & Wu, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.016 · Cited by 445 · see citing works
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
van Schouwenburg, P. A., Rispens, T., & Wolbink, G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.4 · Cited by 441 · see citing works
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 440 · see citing works
Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains
Emmerich, C. H., Ordureau, A., Strickson, S., Arthur, J. S. C., Pedrioli, P. G. A., Komander, D., & Cohen, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314715110 · Cited by 433 · see citing works
The Distinct Roles of TRAF2 and RIP in IKK Activation by TNF-R1
Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M. A., & Liu, Z.-G. (2000) · Immunity · doi:10.1016/s1074-7613(00)80194-6 · Cited by 433 · see citing works
Functional complementation between FADD and RIP1 in embryos and lymphocytes
Zhang, H., Zhou, X., McQuade, T. J., Li, J., Chan, F. K.-M., & Zhang, J. (2011) · Nature · doi:10.1038/nature09878 · Cited by 422 · see citing works
Mitochondrial cell death effectors
Brenner, D., & Mak, T. W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.09.004 · Cited by 416 · see citing works
Self-citationTumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE
Adrain, C., Zettl, M., Christova, Y., Taylor, N. A., & Freeman, M. (2012) · Science · doi:10.1126/science.1214400 · Cited by 407 · see citing works
How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
Schett, G., Elewaut, D., McInnes, I. B., Dayer, J.-M., & Neurath, M. F. (2013) · Nature Medicine · doi:10.1038/nm.3260 · Cited by 406 · see citing works
Casper Is a FADD- and Caspase-Related Inducer of Apoptosis
Shu, H., Halpin, D. R., & Goeddel, D. V. (1997) · Immunity · doi:10.1016/s1074-7613(00)80450-1 · Cited by 399 · see citing works
Slifman, N. R., Gershon, S. K., Lee, J., Edwards, E. T., & Braun, M. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10758 · Cited by 385 · see citing works
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory, A., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 384 · see citing works
The RIP kinases: crucial integrators of cellular stress
Meylan, E., & Tschopp, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.003 · Cited by 383 · see citing works
Berger, S. B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400499 · Cited by 374 · see citing works
c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling
Dynek, J. N., Goncharov, T., Dueber, E. C., Fedorova, A. V., Izrael-Tomasevic, A., Phu, L., Helgason, E., Fairbrother, W. J., Deshayes, K., Kirkpatrick, D. S., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.300 · Cited by 350 · see citing works
Survival Function of the FADD-CASPASE-8-cFLIPL Complex
Dillon, C. P., Oberst, A., Weinlich, R., Janke, L. J., Kang, T.-B., Ben-Moshe, T., Mak, T. W., Wallach, D., & Green, D. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.03.010 · Cited by 331 · cited 2× · see citing works
“This crucial interplay between the inhibition of caspase activity and RIPK1-and RIPK3-mediated necrotic cell death has been clearly demonstrated by the finding that genetic deletion of RIPK1 and/or RIPK3 rescues the lethality observed in caspase 8-deficient or FADD-deficient mice 86,87,106–108 .”
BackgroundSelf-citationiRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS
McIlwain, D. R., Lang, P. A., Maretzky, T., Hamada, K., Ohishi, K., Maney, S. K., Berger, T., Murthy, A., Duncan, G. S., Xu, H. C., et al. (2012) · Science · doi:10.1126/science.1214448 · Cited by 327 · see citing works
Self-citationRasper, D., Vaillancourt, J. P., Hadano, S., Houtzager, V. M., Seiden, I. M., Keen, S., Tawa, P., Xanthoudakis, S., Nasir, J., Martindale, D. W., et al. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400370 · Cited by 316 · see citing works
New targets for mucosal healing and therapy in inflammatory bowel diseases
Neurath, M. F. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.73 · Cited by 309 · see citing works
Emerging cell and cytokine targets in rheumatoid arthritis
Burmester, G. R., Feist, E., & Dörner, T. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.168 · Cited by 307 · see citing works
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
Kaiser, W. J., Daley-Bauer, L. P., Thapa, R. J., Mandal, P., Berger, S. B., Huang, C., Sundararajan, A., Guo, H., Roback, L., Speck, S. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401857111 · Cited by 291 · see citing works
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 289 · see citing works
Fotin‐Mleczek, M., Henkler, F., Samel, D., Reichwein, M., Haußer, A., Parmryd, I., Scheurich, P., Schmid, J. A., & Wajant, H. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.13.2757 · Cited by 284 · see citing works
Regulated Commitment of TNF Receptor Signaling
Pimentel‐Muiños, F. X., & Seed, B. (1999) · Immunity · doi:10.1016/s1074-7613(00)80152-1 · Cited by 282 · see citing works
c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis
Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., & Lavrik, I. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414425200 · Cited by 281 · see citing works
Self-citationEtanercept Treatment in Children With New-Onset Type 1 Diabetes
Mastrandrea, L. D., Yu, J., Behrens, T., Buchlis, J. G., Albini, C. H., Fourtner, S. H., & Quattrin, T. (2009) · Diabetes Care · doi:10.2337/dc09-0054 · Cited by 280 · see citing works
Ermolaeva, M., Michallet, M., Papadopoulou, N., Utermöhlen, O., Kranidioti, K., Kollias, G. A., Tschopp, J., & Pasparakis, M. (2008) · Nature Immunology · doi:10.1038/ni.1638 · Cited by 277 · see citing works
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation
Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277 · see citing works
Chen, W., Zhou, Z., Li, L., Zhong, C., Zheng, X., Wu, X., Zhang, Y., Ma, H., Huang, D., Li, W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435545 · Cited by 265 · see citing works
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice
Rickard, J. A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N., Lalaoui, N., Lawlor, K. E., Vanyai, H. K., Hall, C. M., et al. (2014) · eLife · doi:10.7554/elife.03464 · Cited by 261 · see citing works
Structural Basis for Recognition of Diubiquitins by NEMO
Lo, Y.-C., Lin, S., Rospigliosi, C. C., Conze, D. B., Wu, C.-J., Ashwell, J. D., Eliezer, D., & Wu, H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.012 · Cited by 259 · see citing works
HOIP Deficiency Causes Embryonic Lethality by Aberrant TNFR1-Mediated Endothelial Cell Death
Peltzer, N., Rieser, E., Taraborrelli, L., Draber, P., Darding, M., Pernaute, B., Shimizu, Y., Sarr, A., Draberova, H., Montinaro, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.066 · Cited by 257 · see citing works
Lee, T. H.-Y., Shank, J., Cusson, N., & Kelliher, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404206200 · Cited by 255 · see citing works
Xu, M., Skaug, B. A., Zeng, W., & Chen, Z. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.002 · Cited by 246 · see citing works
Clinical use of anti-TNF therapy and increased risk of infections
Ali, T., Bronze, Kaitha, Mahmood, Ftaisi, & Stone (2013) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s28801 · Cited by 244 · see citing works
TNFα blockade in human diseases: An overview of efficacy and safety
Lin, J., Ziring, D., Desai, S. B., Kim, S., Wong, M., Korin, Y. D., Braun, J. G., Reed, E. F., Gjertson, D. W., & Singh, R. R. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.012 · Cited by 243 · see citing works
Strategies to improve drug development for sepsis
Fink, M. P., & Warren, H. S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4368 · Cited by 242 · see citing works
Vince, J. E., Pantaki-Eimany, D., Feltham, R., Mace, P. D., Cordier, S. M., Schmukle, A. C., Davidson, A. J., Callus, B. A., Wong, W. W.-L., Gentle, I. E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072256 · Cited by 241 · see citing works
TNF superfamily in inflammatory disease: translating basic insights
Croft, M., Duan, W., Choi, H., Eun, S.-Y., Madireddi, S., & Mehta, A. K. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.10.004 · Cited by 232 · see citing works
Vanlangenakker, N., Bertrand, M. J. M., Bogaert, P., Vandenabeele, P., & Berghe, T. V. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.111 · Cited by 228 · see citing works
Pop, C., Oberst, A., Drąg, M., van Raam, B. J., Riedl, S. J., Green, D. R., & Salvesen, G. S. (2011) · Biochemical Journal · doi:10.1042/bj20101738 · Cited by 225 · see citing works
Pobezinskaya, E. L., Kim, Y., Choksi, S., Morgan, M. J., Li, T., Liu, C., & Liu, Z.-G. (2008) · Nature Immunology · doi:10.1038/ni.1639 · Cited by 216 · see citing works
NF-κB Suppression by the Deubiquitinating Enzyme Cezanne
Enesa, K., Zakkar, M., Chaudhury, H., Luong, L. A., Rawlinson, L. M., Mason, J. C., Haskard, D. O., Dean, J. L. E., & Evans, P. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708690200 · Cited by 213 · see citing works
Yang, Q.-H., & Du, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401253200 · Cited by 213 · see citing works
Seymour, R. E., Hasham, M. G., Cox, G. A., Shultz, L. D., HogenEsch, H., Roopenian, D. C., & Sundberg, J. P. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364403 · Cited by 212 · see citing works
Zheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G., & Wu, H. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.009 · Cited by 206 · see citing works
Regulation of TNF‐α with a focus on rheumatoid arthritis
Moelants, E. A. V., Mortier, A., Damme, J. V., & Proost, P. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.15 · Cited by 205 · see citing works
Verhelst, K., Carpentier, I., Kreike, M., Meloni, L., Verstrepen, L., Kensche, T., Đikić, I., & Beyaert, R. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.240 · Cited by 203 · see citing works
Receptor-interacting protein (RIP) kinase family
Zhang, D., Lin, J., & Han, J. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.10 · Cited by 202 · see citing works
Moss, M. L., Sklair‐Tavron, L., & Nudelman, R. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0797 · Cited by 198 · see citing works
Paradoxical inflammation induced by anti-TNF agents in patients with IBD
Cleynen, I., & Vermeire, S. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.125 · Cited by 193 · see citing works
Structural Insights into RIP3-Mediated Necroptotic Signaling
Xie, T., Peng, W., Yan, C., Wu, J., Gong, X., & Shi, Y. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.044 · Cited by 192 · see citing works
Park, Y. C., Ye, H., Hsia, C. Y., Segal, D., Rich, R. L., Liou, H.-C., Myszka, D. G., & Wu, H. (2000) · Cell · doi:10.1016/s0092-8674(00)80889-2 · Cited by 188 · see citing works
Challenges and approaches for the development of safer immunomodulatory biologics
Sathish, J. G., Sethu, S., Bielsky, M.-C., de Haan, L., French, N. S., Govindappa, K., Green, J., Griffiths, C. E. M., Holgate, S. T., Jones, D., et al. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3974 · Cited by 186 · see citing works
Tumor necrosis factor induces GSK3 kinase–mediated cross-tolerance to endotoxin in macrophages
Park, S. H., Park‐Min, K., Chen, J., Hu, X., & Ivashkiv, L. B. (2011) · Nature Immunology · doi:10.1038/ni.2043 · Cited by 176 · see citing works
van de Putte, L. B. A., Rau, R., Breedveld, F. C., Kalden, J. R., Malaise, M. G., van Riel, P. L. C. M., Schattenkirchner, M., Emery, P., Burmester, G. R., Zeidler, H., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.009563 · Cited by 176 · see citing works
Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary
Lopez-Diego, R., & Weiner, H. (2008) · Nature reviews. Drug discovery · doi:10.1038/nrd2358 · Cited by 173 · see citing works
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis
Issuree, P. D. A., Maretzky, T., McIlwain, D. R., Monette, S., Qing, X., Lang, P. A., Swendeman, S. L., Park‐Min, K., Binder, N. B., Kalliolias, G. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66168 · Cited by 162 · see citing works
Self-citationZheng, L., Bidère, N., Staudt, D., Cubre, A., Orenstein, J. M., Chan, F. K.-M., & Lenardo, M. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3505-3513.2006 · Cited by 155 · see citing works
Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis
Lv, S., Han, M. A. T., Yi, R., Kwon, S., Dai, C., & Wang, R. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12382 · Cited by 154 · see citing works
Thalayasingam, N., & Isaacs, J. D. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.004 · Cited by 138 · see citing works
Monoclonal antibody therapy-associated neurological disorders
the BIOGEAS Study Group, Bosch, X., Saiz, A., & Ramos‐Casals, M. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.1 · Cited by 137 · see citing works
Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism
Ban, L., Zhang, J. Y., Wang, L., Kühtreiber, W. M., Burger, D., & Faustman, D. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803429105 · Cited by 127 · see citing works
Phosphodiesterase 4-targeted treatments for autoimmune diseases
Kumar, N., Goldminz, A. M., Kim, N., & Gottlieb, A. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-96 · Cited by 121 · see citing works
Infectious and Malignant Complications of TNF Inhibitor Therapy in IBD
Targownik, L. E., & Bernstein, C. N. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.294 · Cited by 118 · see citing works
Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors
Chen, N., Chio, I. I. C., Lin, W., Duncan, G. S., Chau, H., Katz, D., Huang, H.-L., Pike, K. A., Hao, Z., Su, Y.-W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806585105 · Cited by 116 · see citing works
Self-citationStructural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2
Yin, Q., Lamothe, B., Darnay, B. G., & Wu, H. (2009) · Biochemistry · doi:10.1021/bi901462e · Cited by 112 · see citing works
Kavuri, S. M., Geserick, P., Berg, D., Dimitrova, D. P., Feoktistova, M., Siegmund, D., Gollnick, H., Neumann, M., Wajant, H., & Leverkus, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148585 · Cited by 92 · see citing works
CARP-2 Is an Endosome-Associated Ubiquitin Ligase for RIP and Regulates TNF-Induced NF-κB Activation
Liao, W., Xiao, Q., Tchikov, V., Fujita, K.-I., Yang, W., Wincovitch, S., Garfield, S. H., Conze, D. B., El‐Deiry, W. S., Schütze, S., et al. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.017 · Cited by 83 · see citing works
Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
Prieto‐Pérez, R., Cabaleiro, T., Daudén, E., Ochoa, D., Román, M. C., & Abad‐Santos, F. (2013) · Autoimmune Diseases · doi:10.1155/2013/613086 · Cited by 78 · see citing works
Induction of the NF-κB Cascade by Recruitment of the Scaffold Molecule NEMO to the T Cell Receptor
Weil, R., Schwamborn, K., Alcover, A., Chable-Bessia, C., Bartolo, V. D., & Israël, A. (2003) · Immunity · doi:10.1016/s1074-7613(02)00506-x · Cited by 71 · see citing works
New drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors
Bonilla-Hernán, M.-G., Miranda‐Carús, M., & Martín-Mola, E. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker192 · Cited by 60 · see citing works
Tack, C. J., Kleijwegt, F. S., van Riel, P. L. C. M., & Roep, B. O. (2009) · Diabetologia · doi:10.1007/s00125-009-1381-0 · Cited by 54 · see citing works
Future prospects in biologic therapy for systemic lupus erythematosus
Stohl, W. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.136 · Cited by 52 · see citing works
Developments in therapies for spondyloarthritis
Sieper, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.40 · Cited by 51 · see citing works
Wilson, T. R., Redmond, K. M., McLaughlin, K. M., Crawford, N., Gately, K. A., O'Byrne, K. J., Le-Clorrenec, C., Holohan, C., Fennell, D. A., Johnston, P. G., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.76 · Cited by 48 · see citing works
Grech, A. P., Gardam, S., Chan, T. D., Quinn, R., Gonzales, R., Basten, A., & Brink, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504849200 · Cited by 47 · see citing works
Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
Richter, F., Liebig, T., Guenzi, E., Herrmann, A., Scheurich, P., Pfizenmaier, K., & Kontermann, R. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072156 · Cited by 40 · see citing works
Mease, P. J. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq285 · Cited by 40 · see citing works
Ryba-Stanisławowska, M. E., Marek-Trzonkowska, N. M., Hak, Ł., Rybarczyk-Kapturska, K., Myśliwiec, M., Trzonkowski, P., & Myśliwska, J. M. (2011) · Cytokine · doi:10.1016/j.cyto.2011.05.006 · Cited by 37 · see citing works
Blay, P. L., Mouterde, G., Barnetche, T., Morel, J., & Combe, B. G. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110982 · Cited by 35 · see citing works
Dahlén, R., Strid, H., Lundgren, A., Isaksson, S., Raghavan, S., Magnusson, M. K., Simrén, M., Sjövall, H., & Öhman, L. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12081 · Cited by 32 · see citing works
TNF-Alpha Antagonism in Severe Asthma?
Desai, D., & Brightling, C. E. (2010) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221310793564218 · Cited by 31 · see citing works
Drug Insight: anti-tumor necrosis factor therapies for the vasculitic diseases
Langford, C. A. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0825 · Cited by 21 · see citing works
Rheumatology and the health of the workforce
Hadler, N. M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9 · Cited by 12 · see citing works
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Flagged first, then by citations
1 of the 182 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- A comprehensive review about the TNFSF and TNFRSF, TNF signalling in cell survival and death, and clinical and therapeutic implications of targeting TNF signalling.
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works
Immunotherapy in colorectal cancer: Rationale, challenges and potential
Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954 · see citing works
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T., Lee, S., & Yang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,762 · see citing works
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
Kalliolias, G. D., & Ivashkiv, L. B. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,390 · see citing works
Reactive Oxygen Species: Drivers of Physiological and Pathological Processes
Checa, J., & Aran, J. M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s275595 · Cited by 1,022 · see citing works
TNF and ROS crosstalk in inflammation
Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008 · see citing works
Self-citationFundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Re, D. P. D., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 979 · see citing works
Necroptosis: Mechanisms and Relevance to Disease
Galluzzi, L., Kepp, O., Chan, F. K.-M., & Kroemer, G. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100247 · Cited by 721 · see citing works
The cytokine network involved in the host immune response to periodontitis
Pan, W., Wang, Q., & Chen, Q. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0064-z · Cited by 709 · see citing works
Converging roles of caspases in inflammasome activation, cell death and innate immunity
Man, S. M., & Kanneganti, T. (2015) · Nature reviews. Immunology · doi:10.1038/nri.2015.7 · Cited by 701 · see citing works
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Kong, D.-H., Kim, Y., Kim, M. K., Jang, J. Y., & Lee, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041057 · Cited by 687 · see citing works
Acute Pancreatitis: Diagnosis and Treatment
Szatmary, P., Grammatikopoulos, T., Cai, W., Huang, W., Mukherjee, R., Halloran, C. M., Beyer, G., & Sutton, R. (2022) · Drugs · doi:10.1007/s40265-022-01766-4 · Cited by 667 · see citing works
The role of IL-1β and TNF-α in intervertebral disc degeneration
Wang, Y., Che, M., Xin, J., Zheng, Z. J., Li, J., & Zhang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110660 · Cited by 626 · see citing works
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2018) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 502 · see citing works
Self-citationUbiquitin ligases in oncogenic transformation and cancer therapy
Senft, D., Qi, J., & Ronai, Z. A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.105 · Cited by 490 · see citing works
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
Ward-Kavanagh, L. K., Lin, W. W., Šedý, J. R., & Ware, C. F. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.019 · Cited by 463 · see citing works
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 455 · see citing works
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
Yin, H., Zhang, X., Yang, P., Zhang, X., Peng, Y., Li, D., Yu, Y., Wu, Y., Wang, Y., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21514-8 · Cited by 410 · see citing works
Mehta, A. K., Gracias, D. T., & Croft, M. (2016) · Cytokine · doi:10.1016/j.cyto.2016.08.003 · Cited by 404 · see citing works
TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
Wajant, H., & Siegmund, D. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00091 · Cited by 389 · see citing works
TNF-α Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration
Yamashita, M., & Passegué, E. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.05.019 · Cited by 387 · see citing works
Tumour necrosis factor signalling in health and disease
Holbrook, J. A., Reyna, S. J. L., Jarosz-Griffiths, H., & McDermott, M. (2019) · F1000Research · doi:10.12688/f1000research.17023.1 · Cited by 379 · see citing works
Modes of Regulated Cell Death in Cancer
Koren, E., & Fuchs, Y. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0789 · Cited by 378 · see citing works
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 359 · see citing works
The promise and challenges of immune agonist antibody development in cancer
Mayes, P. A., Hance, K. W., & Hoos, A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.75 · Cited by 355 · see citing works
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 337 · see citing works
Selected cytokine pathways in rheumatoid arthritis
Noack, M., & Miossec, P. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0619-z · Cited by 307 · see citing works
Cell Death in Liver Diseases: A Review
Shojaie, L., Iorga, A., & Dara, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249682 · Cited by 299 · see citing works
Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses
Feng, H., Zhang, Y.-B., Gui, J., Lemon, S. M., & Yamane, D. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009220 · Cited by 293 · see citing works
TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation
Lafont, E., Draber, P., Rieser, E., Reichert, M., Kupka, S., de Miguel, D., Draberova, H., von Mässenhausen, A., Bhamra, A., Henderson, S., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0229-6 · Cited by 283 · see citing works
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilić, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 282 · see citing works
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
Gough, P., & Myles, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585880 · Cited by 270 · see citing works
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
Josephs, S. F., Ichim, T. E., Prince, S. M., Kesari, S., Marincola, F. M., Escobedo, A. R., & Jafri, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1611-7 · Cited by 258 · see citing works
Álvarez, M. M., Liu, J. C., Santiago, G. T., Cha, B.-H., Vishwakarma, A., Ghaemmaghami, A. M., & Khademhosseini, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.026 · Cited by 257 · see citing works
Cytosolic DNA Sensing in Organismal Tumor Control
Vanpouille-Box, C., Demaria, S., Formenti, S. C., & Galluzzi, L. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.013 · Cited by 250 · see citing works
Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
Caldito, N. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1213448 · Cited by 240 · see citing works
Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection
Orzalli, M. H., & Kagan, J. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.05.007 · Cited by 238 · see citing works
Park, S. H., Kang, K., Γιαννοπούλου, Ε., Qiao, Y., Kang, K., Kim, G., Park‐Min, K., & Ivashkiv, L. B. (2017) · Nature Immunology · doi:10.1038/ni.3818 · Cited by 237 · see citing works
Necroinflammation in Kidney Disease
Mulay, S. R., Linkermann, A., & Anders, H. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040405 · Cited by 231 · see citing works
TNF in the liver: targeting a central player in inflammation
Tiegs, G., & Horst, A. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00910-2 · Cited by 231 · see citing works
Dufva, O., Koski, J., Maliniemi, P., Ianevski, A., Klievink, J., Leitner, J., Pölönen, P., Hohtari, H., Saeed, K., Hannunen, T., et al. (2020) · Blood · doi:10.1182/blood.2019002121 · Cited by 224 · see citing works
TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death
Borghi, A., Verstrepen, L., & Beyaert, R. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.03.009 · Cited by 218 · see citing works
Cytokine-Induced Modulation of Colorectal Cancer
Mager, L. F., Wasmer, M.-H., Rau, T. T., & Krebs, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00096 · Cited by 215 · see citing works
Remick, B. C., Gaidt, M. M., & Vance, R. E. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-031732 · Cited by 209 · see citing works
Yang, Y. M., & Seki, E. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0093-z · Cited by 197 · see citing works
Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential
Sharma, V., Singh, T. G., Singh, S., Garg, N., & Dhiman, S. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03418-7 · Cited by 197 · see citing works
Death in the intestinal epithelium—basic biology and implications for inflammatory bowel disease
Blander, J. M. (2016) · FEBS Journal · doi:10.1111/febs.13771 · Cited by 191 · see citing works
Wu, X., Poulsen, K. L., Sanz‐García, C., Huang, E., McMullen, M. R., Roychowdhury, S., Dasarathy, S., & Nagy, L. E. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.023 · Cited by 182 · see citing works
Tumor Necrosis Factor-α in Heart Failure: an Updated Review
Schumacher, S. M., & Prasad, S. V. N. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1067-7 · Cited by 179 · see citing works
Balancing Immune Protection and Immune Pathology by CD8+ T-Cell Responses to Influenza Infection
Duan, S., & Thomas, P. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00025 · Cited by 178 · see citing works
Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
Medler, J., & Wajant, H. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1586886 · Cited by 177 · see citing works
Host pathogen interactions in Helicobacter pylori related gastric cancer
Chmiela, M., Karwowska, Z., Gonciarz, W., Allushi, B., & Stączek, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i9.1521 · Cited by 176 · see citing works
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
Rosenbaum, S. R., Wilski, N. A., & Aplin, A. E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0805 · Cited by 172 · see citing works
Das, T., Chen, Z., Hendriks, R. W., & Kool, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00104 · Cited by 166 · see citing works
Kusnadi, A., Park, S. H., Yuan, R., Pannellini, T., Γιαννοπούλου, Ε., Oliver, D., Lu, T. T., Park‐Min, K., & Ivashkiv, L. B. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.005 · Cited by 156 · see citing works
Jiang, Y., Li, K., Li, X., Xu, L., & Yang, Z. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109452 · Cited by 154 · see citing works
The TNF–TNFR Family of Co-signal Molecules
So, T., & Ishii, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_3 · Cited by 153 · see citing works
Mu, J., Li, C., Shi, Y., Liu, G., Zou, J., Zhang, D., Jiang, C., Wang, X., He, L., Huang, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29772-w · Cited by 143 · see citing works
Wang, M., Zhai, X., Li, J., Guan, J., Xu, S., Li, Y., & Zhu, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670391 · Cited by 141 · see citing works
Kanda, M., Mizuno, A., Tanaka, C., Kobayashi, D., Fujiwara, M., Iwata, N., Hayashi, M., Yamada, S., Nakayama, G., Fujii, T., et al. (2016) · Medicine · doi:10.1097/md.0000000000003781 · Cited by 137 · see citing works
Dozio, V., & Sanchez, J. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1302705 · Cited by 135 · see citing works
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
Guo, Z., Zhang, Z., Prajapati, M., & Li, Y. (2021) · Viruses · doi:10.3390/v13091876 · Cited by 134 · see citing works
Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration
Badran, Y. R., Dedeoğlu, F., Leyva-Castillo, J. M., Bainter, W., Ohsumi, T. K., Bousvaros, A., Goldsmith, J. D., Geha, R. S., & Chou, J. S. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160724 · Cited by 123 · see citing works
Marra, F., Lo, E. A., Kalashnikov, V., & Richardson, K. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw205 · Cited by 122 · see citing works
TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis
Wu, J., Lin, S., Chen, W., Lian, G., Wu, W., Chen, A., Sagor, M. I. H., Luo, L., Wang, H., & Xie, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01365-6 · Cited by 121 · see citing works
Chen, Y., Tan, W., & Wang, C. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s168317 · Cited by 120 · see citing works
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review
Plantone, D., Pardini, M., Righi, D., Manco, C., Colombo, B. M., & Stefano, N. D. (2023) · Cells · doi:10.3390/cells13010054 · Cited by 119 · see citing works
Cytokine and chemokine regulation of venous thromboembolism
Najem, M. Y., Couturaud, F., & Lemarié, C. A. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14759 · Cited by 117 · see citing works
Acute inflammation regulates neuroregeneration through the NF-κB pathway in olfactory epithelium
Chen, M., Reed, R. R., & Lane, A. P. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620664114 · Cited by 116 · see citing works
TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
Sheng, Y., Li, F., & Qin, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01170 · Cited by 116 · see citing works
Neuroimmune Communication in Health and Disease
Reardon, C., Murray, K. M., & Lomax, A. E. (2018) · Physiological Reviews · doi:10.1152/physrev.00035.2017 · Cited by 116 · see citing works
Li, X., Zhong, C., Wu, R., Xu, X., Yang, Z., Cai, S., Wu, X., Chen, X., Yin, Z., He, Q., et al. (2021) · Protein & Cell · doi:10.1007/s13238-020-00810-x · Cited by 116 · see citing works
Extracellular signals regulate the biogenesis of extracellular vesicles
Jin, Y., Ma, L., Zhang, W., Yang, W., Feng, Q., & Wang, H. (2022) · Biological Research · doi:10.1186/s40659-022-00405-2 · Cited by 115 · see citing works
Jia, B., Zhang, B., Li, J., Qin, J., Huang, Y., Huang, M., Ming, Y., Jiang, J., Chen, R., Xiao, Y., et al. (2024) · Chemical Society Reviews · doi:10.1039/d3cs01039b · Cited by 115 · see citing works
Wang, W. T., Kong, P., Ma, G., Li, L., Zhu, J., Xia, T., Xie, H., Zhou, W., & Wang, S. (2017) · Oncotarget · doi:10.18632/oncotarget.17858 · Cited by 114 · see citing works
Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology
de, M. M., Kumar, R., Rivera, F. D. L., Amante, F. H., Sheel, M., Faleiro, R. J., Bunn, P. T., Best, S. E., Beattie, L., Ng, S. S., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005398 · Cited by 113 · see citing works
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
Tan, W., Luo, X., Li, W., Zhong, J., Cao, J., Zhu, S., Chen, X., Zhou, R., Shang, C., & Chen, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.047 · Cited by 113 · see citing works
Interplay between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy
Loftus, L. V., Amend, S. R., & Pienta, K. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094723 · Cited by 112 · see citing works
Preoperative predictors of postoperative complications after gastric cancer resection
Kanda, M. (2019) · Surgery Today · doi:10.1007/s00595-019-01877-8 · Cited by 111 · see citing works
The metalloprotease ADAM17 in inflammation and cancer
Düsterhöft, S., Lokau, J., & Garbers, C. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.04.002 · Cited by 110 · see citing works
Xia, Y., Inoue, K., Du, Y., Baker, S. J., Reddy, E. P., Greenblatt, M. B., & Zhao, B. (2022) · Nature Communications · doi:10.1038/s41467-022-31475-1 · Cited by 110 · see citing works
Fan, W., Guo, J., Gao, B., Zhang, W., Ling, L., Xu, T., Pan, C., Li, L., Chen, S., Wang, H., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aaw3423 · Cited by 109 · see citing works
Importance of TNF-alpha and its alterations in the development of cancers
Sharif, P. M., Jabbari, P., Razi, S., Keshavarz‐Fathi, M., & Rezaei, N. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155066 · Cited by 109 · see citing works
Li, J., Yao, Y.-M., & Tian, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701163 · Cited by 109 · see citing works
Insights into the biology and therapeutic implications of TNF and regulatory T cells
Salomon, B. L. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00639-6 · Cited by 106 · see citing works
A pairwise cytokine code explains the organism-wide response to sepsis
Takahama, M., Patil, A., Johnson, K., Cipurko, D., Miki, Y., Taketomi, Y., Carbonetto, P. S., Plaster, M., Richey, G., Pandey, S., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01722-8 · Cited by 106 · see citing works
Zhao, S., Jiang, J., Jing, Y., Liu, W., Yang, X. F., Hou, X., Gao, L., & Wei, L. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2264-z · Cited by 105 · see citing works
Xu, J., Sun, Y., Li, Y., Ruthel, G. T., Weiss, S. R., Raj, A., Beiting, D. P., & López, C. B. (2017) · Nature Communications · doi:10.1038/s41467-017-00909-6 · Cited by 104 · see citing works
Mancini, S. J., White, A. D., Bijland, S., Rutherford, C. L., Graham, D., Richter, E. A., Viollet, B., Touyz, R. M., Palmer, T. M., & Salt, I. P. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.010 · Cited by 103 · see citing works
Manzoni, T. B., & López, C. B. (2018) · Future Virology · doi:10.2217/fvl-2018-0021 · Cited by 101 · see citing works
Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Nara, Y., Pramusita, A., Kinjo, R., Ma, J., Kanou, K., & Mizoguchi, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031481 · Cited by 101 · see citing works
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
Taraborrelli, L., Peltzer, N., Montinaro, A., Kupka, S., Rieser, E., Hartwig, T., Sarr, A., Darding, M., Dráber, P., Haas, T. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06155-8 · Cited by 100 · see citing works
Yap, J. L., Chen, L., Lanning, M. E., & Fletcher, S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01888 · Cited by 99 · see citing works
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer
Gong, K., Guo, G., Gerber, D. E., Gao, B., Peyton, M., Huang, C., Minna, J. D., Hatanpaa, K. J., Kernstine, K., Cai, L., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96148 · Cited by 98 · see citing works
Granulocyte-derived TNFα promotes vascular and hematopoietic regeneration in the bone marrow
Bowers, E., Slaughter, A., Frenette, P. S., Kuick, R. D., Pello, Ó. M., & Lucas, D. (2017) · Nature Medicine · doi:10.1038/nm.4448 · Cited by 98 · see citing works
Abdu, S. B. S., Juaid, N., Amin, A., Moulay, M., & Miled, N. (2022) · Molecules · doi:10.3390/molecules27228082 · Cited by 98 · see citing works
Ortega, M. S., Denicol, A. C., Cole, J. B., Null, D. J., & Hansen, P. J. (2016) · Animal Genetics · doi:10.1111/age.12420 · Cited by 97 · see citing works
A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway
Quickelberghe, E. V., Sutter, D. D., Loo, G., Eyckerman, S., & Gevaert, K. (2018) · Scientific Data · doi:10.1038/sdata.2018.289 · Cited by 97 · see citing works
A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer
Chan, J. J., Kwok, Z. H., Chew, X. H., Zhang, B., Liu, C., Soong, T. W., Yang, H. H., & Tay, Y. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1248 · Cited by 95 · see citing works
Development of Mcl-1 inhibitors for cancer therapy
Negi, A., & Murphy, P. V. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113038 · Cited by 95 · see citing works
- Authors
- Brenner, D., Blaser, H., & Mak, T. W.
- Affiliations
- Luxembourg Institute of Health (LU)
- University Health Network (CA)
- Corresponding author
- Brenner, Dirk
- Venue
- Nature Reviews Immunology
- Published
- 2015-05-26
- Volume
- 15
- Issue
- 6
- Pages
- 362-374
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1572664742
- Cited by
- 998
- References
- 182
- Citations by year
- 2026: 52 · 2025: 88 · 2024: 81 · 2023: 97 · 2022: 100 · 2021: 112 · 2020: 107 · 2019: 94 · 2018: 96 · 2017: 84 · 2016: 75 · 2015: 11
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- Funders
- Fonds National de la Recherche Luxembourg
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- TNF-α, cell survival, apoptosis, regulated necrosis, inflammatory diseases, autoimmune disease, arthritis, inflammatory bowel disease, inflammatory cytokines
- MeSH terms
- Animals, Autoimmune Diseases, Cell Communication, Homeostasis, Humans, Inflammation, Tumor Necrosis Factor-alpha, NF-kappa B, Apoptosis, Membrane Microdomains, Ubiquitination, Activation, Metabolic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review